File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Book Chapter: Nasopharyngeal Cancer
| Title | Nasopharyngeal Cancer |
|---|---|
| Authors | |
| Issue Date | 2018 |
| Publisher | Demos Medical, an imprint of Springer Publishing |
| Citation | Nasopharyngeal Cancer. In Argiris, A, Ferris, RL and Rosenthal, DI (Eds.), Head and Neck Cancer: Evidence-based Treatment. . New York: Demos Medical, an imprint of Springer Publishing, 2018 How to Cite? |
| Abstract | Nasopharyngeal cancer (NPC) is a significant healthcare burden in endemic areas and Epstein–Barr virus (EBV) infection plays a crucial role in pathogenesis. The management has evolved in the past decades to transform this once very deadly cancer to a highly treatable one. Advances in radiation therapy (RT) technique and systemic treatment have substantially improvedthe treatment outcome. Although the prognosis of early NPC is favorable, long-term toxicity and quality of life issues continue to be the major problems of survivorship. On the other hand, patients with locoregionally advanced disease still suffer from a considerable rate of treatment failure and the prognosis is extremely poor for those with distant metastasis. Future research should focus on risk-adapted treatment strategies in order to achieve the ultimate goal of personalized medicine. Immunotherapy is an exciting area to explore and the results of ongoing studies are eagerly awaited. |
| Persistent Identifier | http://hdl.handle.net/10722/275678 |
| ISBN |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ng, WT | - |
| dc.contributor.author | Chan, OSH | - |
| dc.contributor.author | Sze, HCK | - |
| dc.contributor.author | Lam, KO | - |
| dc.contributor.author | Lee, WMA | - |
| dc.date.accessioned | 2019-09-10T02:47:25Z | - |
| dc.date.available | 2019-09-10T02:47:25Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Nasopharyngeal Cancer. In Argiris, A, Ferris, RL and Rosenthal, DI (Eds.), Head and Neck Cancer: Evidence-based Treatment. . New York: Demos Medical, an imprint of Springer Publishing, 2018 | - |
| dc.identifier.isbn | 9780826137777 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/275678 | - |
| dc.description.abstract | Nasopharyngeal cancer (NPC) is a significant healthcare burden in endemic areas and Epstein–Barr virus (EBV) infection plays a crucial role in pathogenesis. The management has evolved in the past decades to transform this once very deadly cancer to a highly treatable one. Advances in radiation therapy (RT) technique and systemic treatment have substantially improvedthe treatment outcome. Although the prognosis of early NPC is favorable, long-term toxicity and quality of life issues continue to be the major problems of survivorship. On the other hand, patients with locoregionally advanced disease still suffer from a considerable rate of treatment failure and the prognosis is extremely poor for those with distant metastasis. Future research should focus on risk-adapted treatment strategies in order to achieve the ultimate goal of personalized medicine. Immunotherapy is an exciting area to explore and the results of ongoing studies are eagerly awaited. | - |
| dc.language | eng | - |
| dc.publisher | Demos Medical, an imprint of Springer Publishing | - |
| dc.relation.ispartof | Head and Neck Cancer: Evidence-based Treatment. | - |
| dc.title | Nasopharyngeal Cancer | - |
| dc.type | Book_Chapter | - |
| dc.identifier.email | Lam, KO: lamkaon@hku.hk | - |
| dc.identifier.email | Lee, WMA: awmlee@hkucc.hku.hk | - |
| dc.identifier.authority | Lam, KO=rp01501 | - |
| dc.identifier.authority | Lee, WMA=rp02056 | - |
| dc.description.nature | link_to_subscribed_fulltext | - |
| dc.identifier.doi | 10.1891/9780826137784.0016 | - |
| dc.identifier.hkuros | 303058 | - |
| dc.publisher.place | New York | - |